血清涎液化糖链抗原对急性百草枯中毒患者28天死亡的预测价值

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1109 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the value of the expression levels of KL-6 in serum at different time points in the evaluation of 28-day death in patients with acute paraquat poisoning. Methods Seventy-two patients with acute paraquat poisoning admitted to the 960th Hospital of PLA Joint Logistics Support Force from December 2015 to December 2021 were selected. The expression of KL-6 at admission, KL-6(6h), KL-6(24h) in serum, arterial blood gas and biochemical indexes were measured. The correlation between serological indexes of 3 time nodes was analyzed. The influencing factors that affected the outcome were analyzed by logistics regression analysis. The work characteristic curves (ROC curves) of KL-6 at admission, KL-6(6h), KL-6(24 h) in serum were drawn and the area under the curve (AUC) was compared. Results Toxic dose of patients [survival group (58.5±13.2) mg/kg vs death group (155.9±20.5) mg/kg)] and urinary paraquat concentration [survival group ( 34.7±40.1) μg/mL vs death group (343.6±300.9)μg/mL ]were significantly associated with death (P<0.05). Serum KL-6 at 6 h after admission (887.0±39.7 vs 1034.2±33.1 U/mL) and 24 h (1223.0±74.4 vs 1945.3±80.7 U/mL) had predictive value on 28 d death in patients with acute paraquat poisoning. The AUC of serum KL-6 at 24 h after admission was greater than that at 6 h after admission (0.912 vs 0.700, P<0.05). Conclusions The expression of KL-6(6h) and KL-6(24h) in serum is helpful in the early prediction of 28-day death in patients with acute paraquat poisoning, and the predictive ability of serum KL-6 at 24 h after admission is the best.

Key words： KL-6 paraquat prognosis

Received: 19 July 2023

ZTFLH:

R595.4

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHOU Xiaopin
	LIU Bin
	LI Huili
	ZHANG Tiehan

Cite this article:

ZHOU Xiaopin,LIU Bin,LI Huili等. Predictive value of KL-6 in serum for 28-day death in patients with acute paraquat poisoning[J]. Med. J. Chin. Peop. Armed Poli. Forc., 2024, 35(1): 10-13.

URL:

http://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR http://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2024/V35/I1/10

[4]	杜文峰,周玲,李琪.血清KL-6对特发性肺纤维化患者诊断及预后的意义[J].中华肺部疾病杂志(电子版),2022,15(2):218-220.
[1]	Chuanzhu W,Qinbao W,Tong L, et al. Krebs von den Lungen-6 (KL-6) as a diagnostic marker for pulmonary fibrosis: a systematic review and meta-analysis.[J]. Clinical biochemistry.2023, 114:30-38.
[5]	Jun W,Xinrui J,Geng L, et al. Identify the early predictor of mortality in patients with acute paraquat poisoning[J]. BioMed Res Int,2020.
[2]	Liu Y,Yang Z,Ning W.Cell type specific expression of follistatin-like 1 (Fstl1) in mouse embryonic lung development.[J]. J Mol Histol,2018, 49(4):399-409.
[6]	Yamakawa H,Hagiwara E,Ikeda S,et al. Evaluation of changes in the serum levels of krebs von den lungen-6 and surfactant protein-D over time as important biomarkers in idiopathic fibrotic nonspecific interstitial pneumonia. Respir Investig.2019,57(5):422-429.
[3]	VallonthaielAG ,Walia R,Pramanik R,et al.P40 in metastatic pulmonary trophoblastic tumour: potential diagnostic pitfall on his-topathology[J]. Malays J Pathol,2017,39(2):175-179.
[7]	Chen F,Lu X,Shu X.et al.Predictive value of serum markers for the development of interstitial lung disease in patients with polymyosistis and dermatomyositis: a comparative and prospective study[J].Inter Med J,2015,6.8.
[4]	杜文峰,周玲,李琪.血清KL-6对特发性肺纤维化患者诊断及预后的意义[J].中华肺部疾病杂志(电子版),2022,15(2):218-220.
[8]	Jiang Y, Luo Q, Han Q, et al. Sequential changes of serum KL-6 predict the progression of interstitial lung disease[J]. J Thorac Dis, 2018,10(8):4705-4714.
[5]	Jun W,Xinrui J,Geng L, et al. Identify the early predictor of mortality in patients with acute paraquat poisoning[J]. BioMed Res Int,2020.
[9]	Mochizuki T,Ikari K,Yano K,et al.Long-term deterioration of interstitial lung disease in patients with rheumatoid arthritis treated with abatacept.[J]. Modern rheumatology,2019,29(3):413-417.
[6]	Yamakawa H,Hagiwara E,Ikeda S,et al. Evaluation of changes in the serum levels of krebs von den lungen-6 and surfactant protein-D over time as important biomarkers in idiopathic fibrotic nonspecific interstitial pneumonia. Respir Investig.2019,57(5):422-429.
[10]	杜艳征,吕春婷.急性百草枯中毒患者预后情况及其影响因素分析[J].临床医学工程,2022,29(6):881-882.
[7]	Chen F,Lu X,Shu X.et al.Predictive value of serum markers for the development of interstitial lung disease in patients with polymyosistis and dermatomyositis: a comparative and prospective study[J].Inter Med J,2015,6.8.
[11]	韩茜,罗群.2018 年特发性肺纤维化诊断临床实践指南与2018年特发性肺纤维化诊断专家共识解读[J].中华结核和呼吸杂志,2018,41(12):923-925.
[8]	Jiang Y, Luo Q, Han Q, et al. Sequential changes of serum KL-6 predict the progression of interstitial lung disease[J]. J Thorac Dis, 2018,10(8):4705-4714.
[12]	Yuta S,Aina G,Toshihiko K,et al. Introduction of h-antigens into oligosaccharides and sugar chains of glycoproteins using highly efficient 1,2-α-l-fucosynthase[J]. Glycobiology,2016,26(11):1235-1247.
[9]	Mochizuki T,Ikari K,Yano K,et al.Long-term deterioration of interstitial lung disease in patients with rheumatoid arthritis treated with abatacept.[J]. Modern rheumatology,2019,29(3):413-417.
[13]	KohashiY,Arai T,Sugimoto C,et al.Clinical impact of emphy-sema evaluated by high-resolution computed tomography on idio-pathic pulmonary fibrosis diagnosed by surgical lung biopsy[J].Respiration,2016,92(4):220-228.
[10]	杜艳征,吕春婷.急性百草枯中毒患者预后情况及其影响因素分析[J].临床医学工程,2022,29(6):881-882.
[14]	李哲,郑艾宜,曹钰等.急性百草枯中毒患者长期预后的研究进展[J].重庆医学,2022,51(17):3025-3028,3033.
[11]	韩茜,罗群.2018 年特发性肺纤维化诊断临床实践指南与2018年特发性肺纤维化诊断专家共识解读[J].中华结核和呼吸杂志,2018,41(12):923-925.
[15]	周毓,周玉祥,叶凯.KL-6在结缔组织病相关间质性肺病中的诊断及预后评估价值研究[J].中国实用医药,2023,18(10):26-30.
[12]	Yuta S,Aina G,Toshihiko K,et al. Introduction of h-antigens into oligosaccharides and sugar chains of glycoproteins using highly efficient 1,2-α-l-fucosynthase[J]. Glycobiology,2016,26(11):1235-1247.
[16]	Bergantini L,Bianchi F,et al. Prognostic biomarkers of sarcoidosis: a comparative study of serum chitotriosidase, ACE, lysozyme, and KL-6 [J] .Disease markers,2019,2019:8565423.
[13]	KohashiY,Arai T,Sugimoto C,et al.Clinical impact of emphy-sema evaluated by high-resolution computed tomography on idio-pathic pulmonary fibrosis diagnosed by surgical lung biopsy[J].Respiration,2016,92(4):220-228.
[17]	Yanaba K, Hasegawa M,Hamaguchi Y, et al. Longitudinal analysis of serum KL-6 levels in patients with systemic sclerosis: association with the activity of pulmonary fibrosis[J].Chest,2013,143(3):814-824.
[14]	李哲,郑艾宜,曹钰等.急性百草枯中毒患者长期预后的研究进展[J].重庆医学,2022,51(17):3025-3028,3033.
[18]	张芮嘉,关晓辉.百草枯中毒的诊治进展[J].中国老年保健医学,2020,18(1):98-100.
[15]	周毓,周玉祥,叶凯.KL-6在结缔组织病相关间质性肺病中的诊断及预后评估价值研究[J].中国实用医药,2023,18(10):26-30.
[19]	孔艳艳,吴晓飞,陶言言,等.百草枯中毒患者血sCD14-T/mCD14水平与病情程度、APACHEⅡ评分有相关性[J].内科急危重症杂志,2023,29(3):222-225.
[16]	Bergantini L,Bianchi F,et al. Prognostic biomarkers of sarcoidosis: a comparative study of serum chitotriosidase, ACE, lysozyme, and KL-6 [J] .Disease markers,2019,2019:8565423.
[20]	TangHsiu H,ChinWei K,ChianWei C, et al. Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study[J]. BMC pulmonary medicine,2021,21(1).
[17]	Yanaba K, Hasegawa M,Hamaguchi Y, et al. Longitudinal analysis of serum KL-6 levels in patients with systemic sclerosis: association with the activity of pulmonary fibrosis[J].Chest,2013,143(3):814-824.
[18]	张芮嘉,关晓辉.百草枯中毒的诊治进展[J].中国老年保健医学,2020,18(1):98-100.
[19]	孔艳艳,吴晓飞,陶言言,等.百草枯中毒患者血sCD14-T/mCD14水平与病情程度、APACHEⅡ评分有相关性[J].内科急危重症杂志,2023,29(3):222-225.
[20]	TangHsiu H,ChinWei K,ChianWei C, et al. Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study[J]. BMC pulmonary medicine,2021,21(1).

[1]	. [J]. Med. J. Chin. Peop. Armed Poli. Forc., 2024, 35(5): 439-442.